HSBC Holdings plc (LON:HSBA – Get Free Report) insider Jonathan (Jon) Bingham bought 22 shares of HSBC stock in a transaction dated Friday, September 27th. The stock was acquired at an average price of GBX 682 ($9.12) per share, with a total value of £150.04 ($200.70).
HSBC Trading Down 0.7 %
Shares of LON:HSBA opened at GBX 664.70 ($8.89) on Wednesday. The firm has a market cap of £121.77 billion, a price-to-earnings ratio of 755.34, a P/E/G ratio of 5.01 and a beta of 0.52. HSBC Holdings plc has a 1 year low of GBX 572.90 ($7.66) and a 1 year high of GBX 725.20 ($9.70). The business has a fifty day simple moving average of GBX 659.01 and a 200 day simple moving average of GBX 664.48.
HSBC Cuts Dividend
The company also recently declared a dividend, which was paid on Friday, September 27th. Stockholders of record on Thursday, August 15th were issued a dividend of $0.10 per share. The ex-dividend date was Thursday, August 15th. This represents a dividend yield of 1.15%. HSBC’s dividend payout ratio is 5,454.55%.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on HSBA
About HSBC
HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions.
Featured Articles
- Five stocks we like better than HSBC
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Upcoming IPO Stock Lockup Period, Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Learn Technical Analysis Skills to Master the Stock Market
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for HSBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HSBC and related companies with MarketBeat.com's FREE daily email newsletter.